Revelation Biosciences (REVB) Short Interest Ratio & Short Volume → The most important AI company you've never heard of (From Manward Press) (Ad) Free REVB Stock Alerts $1.88 -0.07 (-3.42%) (As of 09:45 AM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Revelation Biosciences Short Interest DataCurrent Short Volume17,700 sharesPrevious Short Volume18,500 sharesChange Vs. Previous Month-4.32%Dollar Volume Sold Short$37,299.21Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Outstanding Shares1,630,000 sharesFloat Size1,630,000 sharesShort Percent of Float1.09%Today's Trading Volume1,265 sharesAverage Trading Volume274,293 sharesToday's Volume Vs. Average0% Short Selling Revelation Biosciences ? Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatREVB Short Interest Over TimeREVB Days to Cover Over TimeREVB Percentage of Float Shorted Over Time Ad Monetary GoldDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Revelation Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202417,700 shares $37,299.21 -4.3%1.1%0.1 $2.11 4/15/202418,500 shares $33,762.50 -43.6%1.1%0 $1.83 3/31/202432,800 shares $89,872.00 No Change8.3%0.1 $2.74 3/15/202432,800 shares $79,048.00 -31.5%8.3%0.1 $2.41 2/29/202447,900 shares $174,835.00 +32.7%12.3%0.1 $3.65 2/15/202436,100 shares $109,022.00 -70.0%9.2%0.1 $3.02 Get the Latest News and Ratings for REVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024120,200 shares $1.06 million +526.0%30.8%0.6 $8.80 1/15/2024577,000 shares $8.20 million +27.7%9.3%5.8 $14.22 12/31/2023451,700 shares $226,166.19 +4.7%7.3%6.7 $0.50 12/15/2023431,400 shares $237,701.40 +1,878.9%7.0%7.2 $0.55 11/30/202321,800 shares $15,763.58 -29.5%0.4%0.4 $0.72 11/15/202330,900 shares $19,476.27 +134.1%0.5%0.6 $0.63 10/31/202313,200 shares $7,933.20 -50.6%0.2%0.2 $0.60 10/15/202326,700 shares $18,206.73 +69.0%0.4%0.4 $0.68 9/30/202315,800 shares $10,892.52 +79.6%0.3%0.2 $0.69 9/15/20238,800 shares $6,688.00 +27.5%0.1%0.1 $0.76 8/31/20236,900 shares $4,637.49 -11.5%0.1%0.1 $0.67 8/15/20237,800 shares $5,588.70 +14.7%0.1%0.1 $0.72 7/31/20236,800 shares $5,576.68 -26.9%0.1%0 $0.82 7/15/20239,300 shares $7,786.89 -35.9%0.2%0 $0.84 6/30/202314,500 shares $13,735.85 -74.6%0.3%0 $0.95 6/15/202357,000 shares $63,270.00 -39.8%1.0%0.1 $1.11 5/31/202394,700 shares $99,435.00 +38.5%1.6%0.1 $1.05 5/15/202368,400 shares $77,292.00 -26.8%1.2%0.1 $1.13 4/30/202393,400 shares $100,872.00 -44.9%2.2%0.1 $1.08 3/31/2020100 shares $2,334.00 -90.0%N/A0 $23.34 3/13/20201,000 shares $25,500.00 -9.1%N/A0.2 $25.50 2/28/20201,100 shares $37,609.00 +450.0%N/A0.1 $34.19 2/14/2020200 shares $7,470.00 -71.4%N/A0 $37.35 1/31/2020700 shares $25,305.00 +600.0%N/A0.1 $36.15 1/15/2020100 shares $3,832.00 No ChangeN/A0 $38.32 12/31/2019100 shares $3,940.00 -83.3%N/A0 $39.40 REVB Short Interest - Frequently Asked Questions What is Revelation Biosciences' current short interest? Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 17,700 shares of REVB short. 1.09% of Revelation Biosciences' shares are currently sold short. Learn More on Revelation Biosciences' current short interest. What is a good short interest percentage for Revelation Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.09% of Revelation Biosciences' floating shares are currently sold short. Is Revelation Biosciences' short interest increasing or decreasing? Revelation Biosciences saw a decline in short interest in April. As of April 30th, there was short interest totaling 17,700 shares, a decline of 4.3% from the previous total of 18,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Revelation Biosciences' float size? Revelation Biosciences currently has issued a total of 1,630,000 shares. Some of Revelation Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Revelation Biosciences currently has a public float of 1,630,000 shares. How does Revelation Biosciences' short interest compare to its competitors? 1.09% of Revelation Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Revelation Biosciences: Aravive, Inc. (1.81%), Biophytis S.A. (2.62%), Phio Pharmaceuticals Corp. (4.09%), Longeveron Inc. (3.56%), Mustang Bio, Inc. (0.91%), Notable Labs, Ltd. (0.08%), Agile Therapeutics, Inc. (12.68%), Dermata Therapeutics, Inc. (1.28%), Alzamend Neuro, Inc. (0.47%), 60 Degrees Pharmaceuticals, Inc. (1.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Revelation Biosciences stock? Short selling REVB is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVB shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Revelation Biosciences? A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REVB, which in turn drives the price of the stock up even further. How often is Revelation Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ARAV Short Interest BPTS Short Interest PHIO Short Interest LGVN Short Interest MBIO Short Interest NTBL Short Interest AGRX Short Interest DRMA Short Interest ALZN Short Interest SXTP Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REVB) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldDoes this make you sick?Allegiance GoldTop 5 AI Stocks to Buy for 2024Market Moving Trends